Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-09FDA Approved: NABUMETONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Nabumetone filed by Lupin Pharmaceuticals, indicating an update to the drug's labeling or fo…
-
FDA approval · 2016-05-09FDA Approved: SULINDAC — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sulindac from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-05-09FDA Approved: ETODOLAC — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for etodolac by Apotex Corp., updating the approval status of this generic NSAID.
-
FDA approval · 2016-05-05FDA Approved: TYLENOL 8 HR ARTHRITIS PAIN — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for TYLENOL 8 HR ARTHRITIS PAIN (acetaminophen) submitted by Kenvue Brands LLC.
-
FDA approval · 2016-04-20FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for MELOXICAM submitted by Zydus Pharmaceuticals USA Inc. This action constitutes a supplemental…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
FDA approval · 2016-03-18FDA Approved: ARTHRITIS PAIN RELIEVER — Original Application (CVS PHARMACY, INC)
FDA approves CVS Pharmacy, Inc.'s Arthritis Pain Reliever as an original generic application for diclofenac sodium. The product is an NSAID …
-
FDA approval · 2016-03-16FDA Approved: CELECOXIB — Original Application (McKesson Corporation dba SKY Packaging)
FDA approved the original Abbreviated New Drug Application for a generic celecoxib product manufactured by McKesson Corporation dba SKY Pack…
-
FDA approval · 2016-02-29FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for Leflunomide by Apotex Corp., approving this generic product.
-
FDA approval · 2016-02-25FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to bring ALEVE GELCAPS (naproxen sodium) to market as a new dosage form from Bayer HealthCare LL…
-
FDA approval · 2016-02-22FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi Aria (golimumab) from Janssen Biotech, Inc., under BLA125433, to update the product …
-
FDA approval · 2016-02-15FDA Approved: LEFLUNOMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Leflunomide filed by Chartwell RX, LLC under an active ANDA.
-
FDA approval · 2016-02-08FDA Approved: IBUPROFEN — Supplemental Application (TIME CAP LABORATORIES,INC)
FDA approved a supplemental application for ibuprofen tablets from Time Cap Laboratories, Inc.
-
FDA approval · 2015-12-23FDA Approved: CELECOXIB — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original application for generic celecoxib by Torrent Pharmaceuticals Limited. This marks approval of a generic version of …
-
FDA approval · 2015-12-02FDA Approved: DICLOFENAC SODIUM — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma's original application for diclofenac sodium, granting clearance for its generic NSAID product. It is indica…
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
FDA approval · 2015-09-23FDA Approved: CELECOXIB — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Celecoxib under an Original Application for generic Celecoxib. The approval covers multiple indications common…
-
FDA approval · 2015-09-18FDA Approved: SULFASALAZINE — Supplemental Application (Sunrise Pharmaceutical, Inc.)
FDA granted a supplemental approval for sulfasalazine from Sunrise Pharmaceutical, Inc.
-
FDA approval · 2015-08-28FDA Approved: ARAVA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for ARAVA (leflunomide) submitted by sanofi-aventis U.S. LLC.
-
FDA approval · 2015-08-24FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen by Hikma Pharmaceuticals USA Inc., indicating changes to the product's approval.
-
FDA approval · 2015-08-21FDA Approved: CELECOXIB — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for a generic Celecoxib product. This marks the entry of a generic celecoxib into…
-
FDA approval · 2015-07-01FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Meloxicam, a generic NSAID, confirming continued availability of the pr…
-
FDA approval · 2015-06-19FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) submitted by Pfizer Laboratories Div Pfizer Inc. The approval updates the …
-
FDA approval · 2015-06-09FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' Original Application for celecoxib, enabling a generic version of Celecoxib to enter the market.
-
FDA approval · 2015-05-28FDA Approved: SULINDAC — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
The FDA approved a supplemental application for sulindac from PuraCap Laboratories dba Blu Pharmaceuticals, updating the product’s labeling …